RxDoctor Payments Data

William Loper, MD

Family Medicine · Ridgeland, MSNPI 1881601409

Payments from drug & device makers

$9,362in general payments, 2019–2025

Across 619 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Pfizer$1K
  • AbbVie$1K
  • Merck$550
  • Abbott$540
  • Amgen$465
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$9,30999%
  • Other$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,362 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$534,126
Medicare patients
924
Services billed
12,724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban296$225,897
OzempicSemaglutide151$166,512
JardianceEmpagliflozin135$107,822
Tresiba Flextouch U-100Insulin Degludec102$53,018
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$40,428
JanuviaSitagliptin Phosphate38$38,558
MyrbetriqMirabegron74$34,357
MounjaroTirzepatide30$31,640
XareltoRivaroxaban35$28,957
RybelsusSemaglutide24$27,025
Tresiba Flextouch U-200Insulin Degludec27$26,760
EntrestoSacubitril/Valsartan28$23,757
FarxigaDapagliflozin Propanediol29$22,666
Repatha SureclickEvolocumab40$21,121
Valsartan410$9,614

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,303$225,897296 claims
Novo NordiskOzempic, Rybelsus$1,374$193,538175 claims
Boehringer IngelheimJardiance$222$107,822135 claims
GSKTrelegy Ellipta$349$40,42866 claims
MerckJanuvia$550$38,55838 claims
Astellas Pharma US IncMyrbetriq$49$34,35774 claims
Lilly USA, LLCMounjaro$445$31,64030 claims
AstraZenecaFarxiga, Symbicort$411$30,80258 claims
Johnson & JohnsonXarelto$121$28,95735 claims
NovartisEntresto$422$23,75728 claims
AbbVieLinzess, Synthroid$1,275$14,843108 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$29$4,629586 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Ridgeland

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →